PT. Glaxo Wellcome Indonesia
About This Business
Change location
Dark mode
Switch to dark mode to head towards a more sustainable world together. More info
Healthcare professionals Contact us Search
GSK logo linking to the homepage
Back to main Behind the science magazine
Back to main Company
Company Outstanding people
Company Governance
FEATURED SECTION Our purpose, strategy and culture FEATURED SECTION Outstanding people
Back to main Innovation
Innovation Our leading scientists
Innovation Therapeutic areas
Innovation Clinical trials at GSK
Innovation Partnering with GSK
SPOTLIGHT ON Behind the science magazine Featured section Our leading scientists
Back to main Products
SPOTLIGHT ON Innovation FEATURED WEBSITE GSKPro for healthcare professionals
Back to main Responsibility
Responsibility Global health and health security
Responsibility Environment
Responsibility Ethical standards
Responsibility Responsibility reports
FEATURED SECTION Inclusion SPOTLIGHT ON Our policy positions
Back to main Investors
Investors Financial reports
Investors Dividend and share price
Investors Stock exchange announcements
Investors Shareholder information
Investors Corporate actions
SPOTLIGHT ON Press releases SPOTLIGHT ON Our pipeline
Back to main Media
Spotlight on Behind the science magazine Featured section Conferences
Back to main Careers
Careers Featured careers
Careers Experienced professionals
Experienced professionals Research and development
Careers Early careers
Early careers Graduate programme
Careers How we hire
Spotlight on Outstanding people Spotlight on Inclusion
Switch to dark mode to head towards a more sustainable world together. More info
2024 Annual Report and Responsible Business Performance Report
Read about our strong performance and pipeline momentum in 2024.
Annual Report 2024 Responsibility reports
Close Video
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases.
Purpose, strategy and culture
Why invest in GSK?
Respiratory, immunology and inflammation
deaths each year due to lung diseases
Go to respiratory, immunology and inflammation
people died from cancer in 2022, making it a leading cause of death worldwide
Go to oncology
people living with HIV globally
Go to HIV
Infectious diseases
deaths globally caused by infectious disease
Go to infectious diseases
Behind the science
Discover how we're getting ahead
### ‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic? ### Remission could be possible for people with asthma, giving them a new outlook on life ### ‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease ### ‘Patients can breathe easier today’: Scientific advances in asthma and COPD care could prevent irreversible lung damage ### Advanced technology is increasing the chances of improving outcomes for cancer patients ### Robots, AI, and machine learning: how smart manufacturing is getting medicines and vaccines from factories to patients faster
Read our magazine
Find out what it's like to work with us
Make a difference with us
With our innovation, scale and global partnerships, working with us presents a unique opportunity to impact the lives of billions.
Hear what Zack has to say
Do your best work with us
To get ahead of disease together, continuous growth and development are vital. At GSK you'll expand your skills and build valuable connections, enabling you to do your best work.
Hear what Sarah and Martha have to say
Be yourself with us
We've built an inclusive and supportive culture, so that you can pursue your professional goals without compromising on what matters most.
Hear what Tammeka has to say
Careers at GSK
Positively impacting society and the planet
Access
We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.
Access
Global health and health security
We are committed to change the trajectory of high burden diseases in lower-income countries with a focus on prevention and treatment of infectious diseases.
Global health and health security
Environment
We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.
Environment
Inclusion
To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and retain the best talent regardless of background, and support all GSK people to thrive.
Inclusion
Ethical standards
Our culture guides our people to do the right thing and act on any concerns they have.
Ethical standards
Product governance
Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.
Product governance
1,461.00 GBp -6.00
Share price at 27 February 2025 17:18
Go to calculator
37.30 USD -0.10
Share price at 27 February 2025 16:00
INVESTORS
We announced our full year and fourth quarter 2024 results on Wednesday 5 February
View latest results
Continue to Company
GSKThis is our global website, intended for visitors seeking information on GSK's worldwide business. Our market sites can be reached by visiting our location selector.